They have a profit making subsidiary that is forecasting $4.2m in revenues in 2020 and also have patents for MPL in the treatment of Alzheimer's, Parkinson's and other degenerative diseases.
Pharmaust Phase II K9 Trial, page-171
-
- There are more pages in this discussion • 389 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $87.55M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $36.85K | 205.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 162181 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 412357 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |